# CytomX Therapeutics, Inc.: filings

CTMX · Nasdaq · CIK 1501989 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ctmx.md) · [Financials](/companies/ctmx/financials.md) · [Filings](/companies/ctmx/filings.md) · [Insiders](/companies/ctmx/insiders.md)

## Reports and events: 196 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 356, 8-K 131, SC 13G/A 43, 3 38, 10-Q 33, SCHEDULE 13G/A 23, SC 13G 20, S-8 14, CORRESP 12, 10-K 11, DEF 14A 11, UPLOAD 10, 424B5 9, D 9, DEFA14A 9, SCHEDULE 13G 9, CT ORDER 8, EFFECT 8, S-3 7, 4/A 5, S-1/A 5, 10-K/A 3, PRE 14A 3, S-3/A 3, SEC STAFF LETTER 2, 144 1, 424B3 1, 424B4 1, 5 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, DRS 1, S-1 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 20:10 ET | [8-K](/filings/0001193125-26-338009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338009 |
| 2026-08-06 | 20:05 ET | [10-Q](/filings/0001193125-26-337950.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337950 |
| 2026-07-27 | 12:05 ET | [8-K](/filings/0001193125-26-316929.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-316929 |
| 2026-06-22 | 20:52 ET | [8-K](/filings/0001193125-26-277631.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-277631 |
| 2026-06-03 | 20:15 ET | [8-K](/filings/0001193125-26-255467.md) | 1.01 Entry into a material agreement | 0001193125-26-255467 |
| 2026-05-07 | 20:12 ET | [8-K](/filings/0001193125-26-211920.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211920 |
| 2026-05-07 | 20:06 ET | [10-Q](/filings/0001193125-26-211868.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211868 |
| 2026-04-30 | 20:16 ET | [DEF 14A](/filings/0001140361-26-018237.md) | Proxy statement, period 2026-06-17 | 0001140361-26-018237 |
| 2026-03-19 | 20:05 ET | [8-K](/filings/0001193125-26-115958.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-115958 |
| 2026-03-16 | 11:04 ET | [8-K](/filings/0001193125-26-107152.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-107152 |
| 2026-03-16 | 11:01 ET | [10-K](/filings/0001193125-26-107146.md) | Annual report, period 2025-12-31 | 0001193125-26-107146 |
| 2025-11-06 | 21:12 ET | [8-K](/filings/0001193125-25-269533.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269533 |
| 2025-11-06 | 21:07 ET | [10-Q](/filings/0001193125-25-269477.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269477 |
| 2025-08-13 | 12:07 ET | [8-K](/filings/0001193125-25-179463.md) | 8.01 Other events | 0001193125-25-179463 |
| 2025-08-07 | 20:16 ET | [8-K](/filings/0000950170-25-105053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105053 |
| 2025-08-07 | 20:06 ET | [10-Q](/filings/0000950170-25-104991.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104991 |
| 2025-06-13 | 20:07 ET | [8-K](/filings/0001193125-25-140739.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-140739 |
| 2025-05-28 | 20:06 ET | [8-K](/filings/0001193125-25-129470.md) | 8.01 Other events | 0001193125-25-129470 |
| 2025-05-13 | 20:05 ET | [8-K](/filings/0001193125-25-118805.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-118805 |
| 2025-05-12 | 10:25 ET | [8-K](/filings/0001193125-25-117245.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-117245 |
| 2025-05-12 | 10:14 ET | [10-Q](/filings/0000950170-25-068511.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068511 |
| 2025-04-28 | 20:15 ET | [DEF 14A](/filings/0001140361-25-016026.md) | Proxy statement, period 2025-06-11 | 0001140361-25-016026 |
| 2025-03-06 | 21:04 ET | [8-K](/filings/0000950170-25-034585.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034585 |
| 2025-03-06 | 21:01 ET | [10-K](/filings/0000950170-25-034575.md) | Annual report, period 2024-12-31 | 0000950170-25-034575 |
| 2025-02-26 | 21:30 ET | [8-K](/filings/0001193125-25-036794.md) | 3.01 Delisting notice | 0001193125-25-036794 |
| 2025-02-03 | 21:02 ET | [8-K](/filings/0001193125-25-019257.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-019257 |
| 2025-01-06 | 21:10 ET | [8-K](/filings/0001193125-25-002165.md) | 2.05 Exit or disposal costs | 0001193125-25-002165 |
| 2024-11-07 | 21:09 ET | [8-K](/filings/0000950170-24-123314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123314 |
| 2024-11-07 | 21:02 ET | [10-Q](/filings/0000950170-24-123249.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123249 |
| 2024-08-08 | 20:08 ET | [8-K](/filings/0000950170-24-093936.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093936 |
| 2024-08-08 | 20:03 ET | [10-Q](/filings/0000950170-24-093865.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093865 |
| 2024-06-17 | 20:35 ET | [8-K](/filings/0001193125-24-162652.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-162652 |
| 2024-05-17 | 20:01 ET | [8-K](/filings/0001193125-24-141699.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-141699 |
| 2024-05-08 | 20:41 ET | [8-K](/filings/0001193125-24-134284.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-134284 |
| 2024-05-08 | 20:04 ET | [8-K](/filings/0000950170-24-055598.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055598 |
| 2024-05-08 | 20:01 ET | [10-Q](/filings/0000950170-24-055588.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055588 |
| 2024-04-04 | 20:31 ET | [DEF 14A](/filings/0001140361-24-017969.md) | Proxy statement, period 2024-05-15 | 0001140361-24-017969 |
| 2024-03-22 | 20:06 ET | [8-K](/filings/0001193125-24-075211.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-075211 |
| 2024-03-11 | 20:02 ET | [8-K](/filings/0000950170-24-029207.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-029207 |
| 2024-03-11 | 20:00 ET | [10-K](/filings/0000950170-24-029191.md) | Annual report, period 2023-12-31 | 0000950170-24-029191 |
| 2023-11-07 | 21:05 ET | [8-K](/filings/0000950170-23-060221.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060221 |
| 2023-11-07 | 21:00 ET | [10-Q](/filings/0000950170-23-060201.md) | Quarterly report, period 2023-09-30 | 0000950170-23-060201 |
| 2023-08-24 | 20:05 ET | [8-K](/filings/0001193125-23-220087.md) | 1.01 Entry into a material agreement | 0001193125-23-220087 |
| 2023-08-08 | 20:08 ET | [8-K](/filings/0000950170-23-039793.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039793 |
| 2023-08-08 | 20:03 ET | [10-Q](/filings/0000950170-23-039761.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039761 |
| 2023-07-03 | 23:07 ET | [8-K](/filings/0001193125-23-180722.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-180722 |
| 2023-06-20 | 20:06 ET | [8-K](/filings/0001193125-23-170124.md) | 5.07 Shareholder vote results | 0001193125-23-170124 |
| 2023-05-09 | 20:12 ET | [8-K](/filings/0000950170-23-019674.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-019674 |
| 2023-05-09 | 20:09 ET | [10-Q](/filings/0000950170-23-019654.md) | Quarterly report, period 2023-03-31 | 0000950170-23-019654 |
| 2023-04-27 | 20:16 ET | [DEF 14A](/filings/0001140361-23-020944.md) | Proxy statement, period 2023-06-14 | 0001140361-23-020944 |

Page 1 of 4. [Older](/companies/ctmx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.